Literature DB >> 35943720

Association between CYP2E1 C-1054T and 96-bp I/D genetic variations and the risk of polycystic ovary syndrome in Chinese women.

Y Pu1, Q Liu1, H Liu2, H Bai1, W Huang2, M Xi2, P Fan3.   

Abstract

PURPOSE: To investigate the association of cytochrome P450 2E1 (CYP2E1) C-1054T (rs2031920) and 96-bp I/D genetic variations with the risk of polycystic ovary syndrome (PCOS), and to estimate the effects of genotypes on the clinical, metabolic, hormonal, and oxidative stress indicators.
METHODS: This case-control study included 762 control women and 1034 patients with PCOS. Genotypes were determined using polymerase chain reaction and/or restriction fragment length polymorphism analysis. Clinical and biochemical parameters were also analyzed.
RESULTS: Frequencies of the TT + CT genotype (35.4 vs. 28.9%) and T allele (19.6 vs. 16.0%) of the CYP2E1 C-1054T polymorphism were significantly higher in the PCOS group than in the control group (OR = 1.350, 95% CI 1.103-1.652, P = 0.004 for the dominant model). Genotype TT + CT remained a significant predictor of PCOS in a logistic regression model including age, body mass index (BMI), and recruitment year of participants (OR = 1.345, 95% CI 1.071-1.688, P = 0.011). No statistical differences were found in the genotype and allele frequencies of CYP2E1 96-bp I/D polymorphism. However, the combined genotype DD/TT + CT was related to an increased risk of PCOS when the DD/CC wild-type combined genotype was used as a reference. Patients with the I allele of 96-bp I/D polymorphism had a lower BMI but higher plasma apolipoprotein B and oxidized low-density lipoprotein cholesterol levels than those with the DD genotype.
CONCLUSION: CYP2E1 C-1054T, but not 96-bp I/D, genetic polymorphism is associated with an increased risk of PCOS in Chinese women.
© 2022. The Author(s), under exclusive licence to Italian Society of Endocrinology (SIE).

Entities:  

Keywords:  CYP2E1; Cytochrome P450; Genetic polymorphism; Oxidative stress; Polycystic ovary syndrome; Xenobiotic metabolism

Year:  2022        PMID: 35943720     DOI: 10.1007/s40618-022-01885-5

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   5.467


  48 in total

Review 1.  Environmental determinants of polycystic ovary syndrome.

Authors:  Sharon Stein Merkin; Jennifer L Phy; Cynthia K Sites; Dongzi Yang
Journal:  Fertil Steril       Date:  2016-05-27       Impact factor: 7.329

2.  A comprehensive review of cytochrome P450 2E1 for xenobiotic metabolism.

Authors:  Jingxuan Chen; Sibo Jiang; Jin Wang; Jwala Renukuntla; Suman Sirimulla; Jianjun Chen
Journal:  Drug Metab Rev       Date:  2019-06-28       Impact factor: 4.518

3.  Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression.

Authors:  N S Kakoly; M B Khomami; A E Joham; S D Cooray; M L Misso; R J Norman; C L Harrison; S Ranasinha; H J Teede; L J Moran
Journal:  Hum Reprod Update       Date:  2018-07-01       Impact factor: 15.610

4.  Cancer risk and PCOS.

Authors:  Daniel A Dumesic; Rogerio A Lobo
Journal:  Steroids       Date:  2013-04-24       Impact factor: 2.668

Review 5.  Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment.

Authors:  Héctor F Escobar-Morreale
Journal:  Nat Rev Endocrinol       Date:  2018-03-23       Impact factor: 43.330

Review 6.  Pregnancy complications in women with polycystic ovary syndrome.

Authors:  Stefano Palomba; Marlieke A de Wilde; Angela Falbo; Maria P H Koster; Giovanni Battista La Sala; Bart C J M Fauser
Journal:  Hum Reprod Update       Date:  2015-06-27       Impact factor: 15.610

Review 7.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

Review 8.  CYP2E1 and risk of chemically mediated cancers.

Authors:  Dimitrios T Trafalis; Eleftheria S Panteli; Anastasios Grivas; Christos Tsigris; Petros N Karamanakos
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-03       Impact factor: 4.481

Review 9.  Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences.

Authors:  Panagiotis Anagnostis; Basil C Tarlatzis; Robert P Kauffman
Journal:  Metabolism       Date:  2017-10-10       Impact factor: 8.694

10.  Conceptualization of functional single nucleotide polymorphisms of polycystic ovarian syndrome genes: an in silico approach.

Authors:  B N Prabhu; S H Kanchamreddy; A R Sharma; S K Bhat; P V Bhat; S P Kabekkodu; K Satyamoorthy; P S Rai
Journal:  J Endocrinol Invest       Date:  2021-01-27       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.